CONMED
CNMD
306 hedge funds and large institutions have $3.99B invested in CONMED in 2023 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 125 increasing their positions, 93 reducing their positions, and 21 closing their positions.
162% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 21
34% more repeat investments, than reductions
Existing positions increased: 125 | Existing positions reduced: 93
11% more capital invested
Capital invested by funds: $3.59B → $3.99B (+$408M)
11% more funds holding
Funds holding: 275 → 306 (+31)
2.94% more ownership
Funds ownership: 115.67% → 118.61% (+2.9%)
7% less call options, than puts
Call options by funds: $18.7M | Put options by funds: $20.1M
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$30M |
| 2 |
Morgan Stanley
New York
|
+$19.5M |
| 3 |
SEI Investments
Oaks,
Pennsylvania
|
+$14.5M |
| 4 |
JFG
Jefferies Financial Group
New York
|
+$13M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$12.8M |
Top Sellers
| 1 |
Norges Bank
Oslo,
Norway
|
-$19.8M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$9.92M |
| 3 |
Two Sigma Investments
New York
|
-$8.94M |
| 4 |
JP Morgan Chase
New York
|
-$8.83M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$7.13M |
CNMD Hedge Fund Activity: Q4 2023 in Review
306 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q4 2023, worth a combined $3.99B — up 11% from $3.59B a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new CNMD positions and 21 closed out — a net gain of 34 holders — while 125 added to existing stakes and 93 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $30M. The largest seller was Norges Bank, cutting an estimated $19.8M.
- 306 institutional investors held CONMED (CNMD) as of Q4 2023, up from 275 in Q3 2023.
- Funds reported $3.99B of CONMED stock for Q4 2023, up 11% quarter-over-quarter.
- 55 funds opened new CONMED positions in Q4 2023 and 21 closed out, a net change of +34 holders.
- The largest CONMED buyer in Q4 2023 was Capital Research Global Investors, an estimated $30M added.
- The largest CONMED seller in Q4 2023 was Norges Bank, an estimated $19.8M sold.
Based on aggregated 13F filings for Q4 2023.